BCTXBriaCell Therapeutics CorporationSigning up patients
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Breast Cancer · Metastatic Breast Cancer · Breast Neoplasm · Breast Cancer Metastatic · End Stage Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 404 (planned)
- Started
- Dec 5, 2023
- Main results expected
- Dec 2027
- Fully finished
- Jun 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Overall Survival
Measured over: Up to 60 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06072612 · record last updated 2026-09-02 · checked 2026-11-09 15:47 UTC